10x Genomics Announces Senior Leadership Changes
-
Mennah Moustafa has been named Chief Commercial Officer, effectiveAugust 1 . In this role, Moustafa will be responsible for driving commercial strategy and execution and leading the company's sales, support and marketing functions. -
Justin McAnear , Chief Financial Officer, will resign from the company effectiveAugust 30 , to join a private company. -
Adam Taich has been appointed Chief Financial Officer, effectiveAugust 12 . Taich will be responsible for leading the company's financial team and strategy.
"For the past two years, we've been intentionally evolving the company to continue to drive strong growth at scale, with across-the-board advances in how we innovate, operate and go-to-market," said Serge Saxonov, CEO and Co-founder. "The changes we're announcing today, along with the recent additions of
"Justin has been a fantastic leader, a valued partner and a trusted friend. He helped to take 10x public, scaled the company and built a strong financial profile that has generated tremendous revenue growth and positive cash flow. As a result, we believe we are in a strong financial position and well set up for the future. On behalf of the Board and everyone at 10x, I want to thank Justin for his immeasurable contributions and wish him the best of luck in his new role.
"With Justin's departure, I'm very excited to welcome Adam to 10x as our Chief Financial Officer. Adam is a seasoned executive and strategic finance leader who has held many leadership roles across functions in both large and small high growth companies. He brings a unique set of industry, strategic and operational perspectives to the role and to our senior team.
"Finally, throughout our extensive search process, Mennah distinguished herself and emerged as the best candidate to lead our commercial function in this next phase. She has done an exceptional job as our interim CCO, building a strong leadership team, setting a clear vision for our commercial strategy and rapidly implementing foundational processes to better enable the success of our customers and our company. I couldn't be more excited to have Mennah at the helm as we work together to build a premier commercial organization that delivers superior execution and superior results."
McAnear said, "It's been an honor to be part of the 10x team over the past six years. I'm extremely proud of how much we have accomplished and how much we have grown – from a single product company to a scaled organization with three leading platforms across single cell and spatial biology. I firmly believe 10x will continue to lead and has a very bright future ahead."
Added Moustafa, "I couldn't be more excited to be working alongside such a talented team as we continue to build a high-performance commercial organization, strengthen our commercial machinery and scale into the future. I see a huge opportunity to advance the field, and the entire commercial team is motivated and rallied to pursue widespread adoption of 10x technologies so we can advance our mission and accelerate the mastery of biology."
Taich said, "I've always believed 10x is one of the most exciting companies in the industry, and I'm thrilled to work with this talented team to drive the next phase of growth and advance the company's mission. I've spent my entire career in the life sciences tools sector in both operating and finance leadership roles. I'm energized by the incredible potential of single cell and spatial biology to transform human health."
About Mennah Moustafa
With more than two decades of commercial and business development experience, Moustafa is an accomplished leader with a proven track record of driving commercial success and building high-performance teams in the biotechnology and life sciences industry. Moustafa joined
Prior to joining
About
Taich joins
Earlier, Taich held a number of senior roles spanning finance, strategy and general management over a nearly 20-year career at Thermo Fisher Scientific, a global supplier of scientific instrumentation, reagents and software services. He spent the first 10 years of his time at Thermo Fisher in finance leadership roles and then transitioned into general management of scaled businesses. Prior to joining Thermo Fisher, he worked in investment banking. Taich holds a bachelor's degree in Political Science and Russian from
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the "safe harbor" provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "see," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "deliver," "potential" or "continue" or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding
Disclosure Information
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-announces-senior-leadership-changes-302218349.html
SOURCE